• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

An investigation of biochemical modulation and negatively autoregulated thymidylate synthase mechanism

Research Project

Project/Area Number 09670591
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionJAPANESE FOUNDATION FOR CANCER RESEARCH

Principal Investigator

AIBA Keisuke  Dept. of Clinical Oncology, Cancer Chemo. Ctr., Associate Director, 癌化学療法センター・臨床部, 副部長 (90150086)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Shunji  Dept. of Clinical Oncology, Cancer Chemo. Ctr., JAPANESE FOUNDATION FOR CANCER RESEARCH, Staff, 癌化学療法センター・臨床部, 研究員 (90221358)
ITO Yoshinori  Dept. of Clinical Oncology, Cancer Chemo. Ctr., JAPANESE FOUNDATION FOR CANCER RESEARCH, Staff, 癌化学療法センター・臨床部, 研究員 (00261131)
HORIKOSHI Noboru  Dept. of Clinical Oncology, Cancer Chemo. Ctr., JAPANESE FOUNDATION FOR CANCER RESEARCH, Director, 癌化学療法センター・臨床部, 部長 (00085648)
MIZUNUMA Nobuyuki  Dept. of Clinical Oncology, Cancer Chemo. Ctr., JAPANESE FOUNDATION FOR CANCER RESEARCH, Staff, 癌化学療法センター・臨床部, 研究員 (40311229)
Project Period (FY) 1997 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 2000: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1999: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1998: ¥600,000 (Direct Cost: ¥600,000)
KeywordsTS / RNA / Biochemical modulator / p53 / Biochemical modulator / biochemical modulation
Research Abstract

1)Binding of thymidylate synthase(TS) protein and TSmRNA
The repressive effect of TSmRNA translation is mediated by direct binding of TS itself to its own mRNA.We synthesized a completely degenerate, linear RNA pool of nucleotides sequences in vitro and isolated a high affinity RNA ligand that bind directly human TS protein through in vitro steps of selection and amplification. This single RNA molecule had binding affinity to TS protein having 20-fold greater than wild-type TS RNA sequences. Structure analysis of this RNA sequence revealed that it had a stem-loop structure having UGU loop element within the RNA sequence. Deletion and/or modification of this specific element within this RNA sequence seemed to be very critical in binding to TS protein.
2)Thymidylate synthase protein has a function as a RNA binding protein
In addition to TS's role in enzyme catalysis, there is evidence that TS also functions as an RNA binding protein. The translation of human TS mRNA is regulated by its own … More protein product via a negative autoregulatory mechanism. RNA gel shift assays revealed a specific interaction between TS protein and the protein-coding region of p53mRNA and in vitro translation studies demonstrated that this interacion resulted in the specific repression of p53mRNA translation. Western immunoblot analysis demonstrated that undetectable levels of p53 protein in TS-overexpressing human colon cancer H630-R10 cell line compared with that in the parent cell line. These findings suggest that TS regulates the expression of p53 at the translational level.
3)An improved schedule of 5-FU administration
TS is negatively autoregulated at the level of TSmRNA translation. To avoid the synthesis of new protein, we have developed a new improved administration schedule with 5-FU giving in a "on and off" manner. In vitro experiments revealed that every 12 hours "on and off" schedule over 96 hrs was nealy identical compared with 96 hrs contunuous exposure schedule. TS inhibition was maintained similarly up to 90% with both methods. Clinical pilot study using 5-FU 750-850mg/m^2 ON/OFF therapy revealed that one PR and seven NCs were obtained with decreased toxicity in patients with advanced gastrointestinal cancer resistant to prior 5-FU therapy. Less

Report

(5 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (75 results)

All Other

All Publications (75 results)

  • [Publications] Lin X, Mizunuma N, Chen T-M, et al.: "In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase."Nucleic Acids Research. 28. 4266-4274 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugiyama K, Uno S, Aiba K, et al.: "An investigation of optimal schedule for 5-fluorouracil single-agent chemotherapy in colorectal cancer."Tokyo Jikeikai Medical J. 115. 583-596 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Inamoto Y, Kuraishi Y, Aiba K, et al.: "Enhancement of 5-fluorouracil cytotoxicity by interleukin-2 against human colon cancer cell lines."Tokyo Jikeikai Medical J. 115. 583-596 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Furue H, Fujita H, Aiba K, et al.: "Clinical aspects of fluoropyrimidines."Cancer up to date. 2. 2-9 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada Y, Aiba K, Horikoshi N, et al.: "Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer."Int J Clin Oncol. 5. 18-21 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Inamoto Y, Aiba K, et al.: "Multimodality therapy with standard cisplatin and protracted infusion of 5-fluorouracil with concurrent hyperfractionated radiation in locally advanced esophageal cancer patients."Jpn J. Chemother. 48. 341-346 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Chu E, Copur SM, Ju J, et al.: "Thymidylate synthase protein and p53 mRNA form an in vivo ribonucle oprotein complex."Molecular and Cellular Biology. 19. 1582-1594 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Igarashi T, Marumo K, Aiba K, et al.: "Interferon-alpha and 5-fluorouracil therapy in patients with metastatic renal cell cancer : an open multicenter trial."Urology. 53. 53-59 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K.: "Antimetabolites."Current Therapy. 17. 36-46 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirata K, Horikoshi N, Aiba K, et al.: "Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug."Clinical Cancer Research. 5. 2000-2005 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sato A, Kurihara M, Aiba K, et al.: "Phase II study of raltitrexed (Tomudex【○!R】) in chemotherapy-pretreated patients with advanced colorectal cancer."Anti-Cancer Drugs . 10. 741-748 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Aiba K, Sugiyama K, et al.: "Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer."Jpn J Cancer Chemother. 26. 229-2232 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Aiba K, Sugiyama K, et al.: "Combined therapy of low dose cisplatin and protracted infusion of 5-fluorouracil with radiotherapy in inoperable esophageal cancer patients."Jpn J. Chemother.. 47. 382-386 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shirasaka T, Aiba K, Araki H, et al.: "Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer."Jpn J Cancer Chemother . 26. 465-466 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K, Kanamaru R, et al.: "Phase I study of oral 1-Leucovorin and UFT combination chemotherapy"Jpn J Cancer Chemother. 25. 531-539 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K, Fukuoka M, et al.: "Phase I study of raltitrexed (ZD-1694)."Jpn J Cancer, Chemother. 25. 2075-2084 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata J, Aiba K, Shibata H, et al.: "Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR."Anticancer Res. 18. 1457-1464 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Fukushima M, Murakami Y, Aiba K, et al.: "The analysis of the innate pathways of 5-fluorouracil phosphorylation in human gastrointestinal cancer cell lines in vitro and in vivo."Oncology Reports. 4. 1188-1194 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K, Mizunuma N, and Uno S: "S-1, Tomudex, Capecitabine."Cancer Clinc. 43. 826-835 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Saji S, Aiba K, Araki H, et al.: "Current status of low dose cisplatin and 5-fluorouracil combination chemotherapy."Jpn J Cancer Chemother. 24. 1892-1900 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K. : "Fluoropyrimidines and antipurine metabolites, in Resistant mechanisms and reversal mechanisms in anticancer drugs."Uchudo Yagi Press, Tokyo. 10 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K.: "Dose intensity and schedule dependency of 5-FU in preclinical model. Chemotherapy for gastrointestinal cancer. In Digestive system disease seminar 80. Sekine T ed."Health Press, Tokyo. 10 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K.: "Upper gastrointestinal tumors. in Cancer Chemotherapy & Biological Response Modifiers."Elsevier Science, Oxford. 10 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K.: "Antimetabolites."Yellow Book 3 Anticancer drugs. Mics.. 57 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, and Aiba K.: "Anticancer, drugs. Fluoropyrimidines. Guide of Therapeutics '97 Tokyo"Bunkodo. 9 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Lin X, Mizunuma N, Chen T-M, Copur SM, Malay GF, Liu J, Malay F, Chu E: "In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase"Nucleic Acids Research. 28. 4266-4274 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugiyama K, Uno S, Aiba K, Mizunuma N, and Kuraishi Y: "An investigation of optimal schedule for 5-fluorouracil single-agent chemotherapy in colorectal cancer"Tokyo Jikeikai Medical J. 115. 583-596 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Inamoto Y, Kuraishi Y, Aiba K, Mizunuma N, and Horikoshi N: "Enhancement of 5-fluorouracil cytotoxicity by interleukin-2 against human colon cancer cell lines"Tokyo Jikeikai Medical J. 115. 583-596 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Furue H, Fujita H, Sasaki T, Aiba K, and Konishi T: "Clinical aspects of fluoropyrimidines"Cancer up to date. 2. 2-9 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada Y, Aiba K, Horikoshi N, Hanai M, Uno S, Osawa H, MizunumaN, Takahashi S, Ito Y: "Pilot study of continuous low-dose 5-fluorourachi and cisplatin (FP regimen)for the treatment of metastatic breast cancer"Int J Clin Oncol. 5. 18-21 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Inamoto Y, Aiba K, Horikoshi N, Yamashita T, Ueda M, Matsubara T: "Multimodaity therapy with standard cisplatin and protracted infusion of 5-fluorouracil with concurrent hyperfactionated radiation in locally advanced esophageal cancer patients"Jpn J.Chemother. 48. 341-346 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Chu E, Copur SM, Ju J, Chem T-M, Khleif S, Voeller DM, Mizunuma N, Patel M, Maley GF, Maley F, Allegra CJ: "Thymidylate synthase protein and p53 mRNA from an in vivo riconucleoprotein complex"Molecular and Cellular Biology. 19. 1582-1594 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Igarashi T, Marumo K, Onishi T, kobayashi M, Aiba K, Tsushima T, Ozono S, Tomita Y, Terachi T, Satomi Y, Kawamura J and The Japanese study group against renal cancer: "Interferonalpha and 5-fluorouracil therapy in patients with metastatic renal cell cancer : an open multicenter trial"Urology. 53. 53-59 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K: "Antimetabolites"Current Therapy. 17. 36-46 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirata K, Horikoshi N.Aiba K, Okazaki M, Denno R, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi and Shirasaka T: "Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug"Clinical Cancer Research. 5. 2000-2005 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sato A, Kurihara M, Horikoshi N, Aiba K, Kikkawa N, Shirouzu K, Mitachi Y, Sakata Y, Wakui A and the 'Tomudex' cooperative study group: "Phase II study of raltitrexed (Tomudex (R))in chemotherapy-pretreated patients with advanced colorectal cancer"Anti-Cancer Drugs. 10. 741-748 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Aiba K, Sugiyama K, Mizunuma N, Takahashi S, Ito Y, Horikoshi N: "Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer"Jpn J Cancer Chemother. 26. 2229-2232 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohsawa H, Aiba K, Sugiyama K, Mizunuma N, Takahashi S, Ito Y, Horikoshi N, Furukawa M, Yamashita T, Matsubara T: "Combined therapy of low dose cisplatin and protracted infusion of 5-fluorouracil with radiotherapy in inoperable esophageal cancer patients"Jpn J.Chemother.. 47. 382-386 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shirasaka T, Aiba K, Araki H, Suzuki M, Terashima M, Mikami Y: "Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin(CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer"Jpn J Cancer Chemother. 26. 456-466 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K, Kanamaru R, HasegawaK, Takeda T, Taguchi T, Nitani H, Furue H, Kurihara M, Ogawa M, and Abe T: "Phase I study of orall-Leucovorin and UFT combination chemotherapy"Jpn J Cancer Chemother. 25. 531-539 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, Aiba K, Fukuoka M, Akazawa S, Sakata Y, Furuse K, Kanamaru R, Kudoh S, Jonishi T, Kurihara M, Niitani H, Frue H, Tsukagoshi S, Taguchi T, Yoshida S, Ota K, Kotake T, Wakui AH, Kurihara M, Ogawa M, and Abe T: "Phase I study of raltitrexed(ZD-1694)"Jpn J Cancer Chemother. 25. 2075-2084 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata J, Aiba K, Shibata H, Minowa W and Horikoshi N: "Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR"Anticancer Res. 18. 1457-1464 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Fukushima M, Murakami Y, Suzuki N and Aiba K: "The analysis of the innate pathways of 5-fluorouracil phosphorylation in human gastrointestinal cancer cell lines in vitro and in vivo"Oncology Reports. 4. 1188-1194 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K, Mizunuma N, and Uno S: "S-1, Tomudex, Capecitabine"Cancer Clinc. 43. 826-835 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Saji S, Aiba K, Araki H, Sasaki K, Shirasaka T, Sowa K, Tanaka M, Zheng Rongxi, Tohge T, Hirata K, Yasumoto K, Yamamitsu S, and Wada H: "Current status of low dose cisplatin and 5-fluorouracil combination chemotherapy"Jpn J Cancer Chemother. 24. 1892-1900 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Horikoshi N, and Aiba K: "Anticancer drugs. Fluoropyrimidines"Guide of Therapeutics '97. Tokyo, Bunkodo. 854-863 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K: "Uchudo Yagi Press, Tokyo"Fluoropyrimidines and antipurine metabolites, in Resistant mechanism and reversal mechanisms in anticancer drugs. 211-221 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K: "Sekine T ed. Health Press, Tokyo"Dose intensity and schedule dependency of 5-FU in preclinical model. Chemotherapy for gastrointestinl cancer. In Digestive system disease seminar 80. 11-22 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K: "Elsevier Science, Oxford"Upper gastrointestinal tumors. in Cancer Chemotherapy & Biological Response Modifiers. Schilsky R, Sondel P and Giaccone G eds. annual 19. (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Aiba K, Takahashi R, Ogawa M.eds.: "Tokyo"Antimetabolites. in Yellow Book 3 Anticancer drugs.. 70-127 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Chu,E.,Mizunuma,N., et al.: "Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex."Molecular and Cellular Biology. 19・2. 1582-1594 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Lin,X.,Mizunuma,N., et al.: "In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase."Nucleic Acids Research. 28. 4266-4274 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Lin,X.,Mizunuma,N., et al.: "In vitro selection of a high-affinity RNA sequence that serves as a Thymidylate synthase-response enhancer element."Nucreic Acids Research. 28. 1381-1389 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamada,Y.,Aiba,K., et al.: "Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer."Int J Clin Oncol. 5. 18-21 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Aiba,K.: "New combination chemotherapies for breast cancer."Int J Cancer Chemother. 27. 362-374 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 相羽惠介,堀越昇: "大腸癌化学療法の最新情報.大腸がんの基礎と臨床."Bio Clinica. 15. 161-165 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Aiba,K.: "Upper gastrointestinal tumors. in Cancer Chemotherapy & Biological Response Modifiers."Elsevier Science, Oxford. (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 相羽惠介: "フッ化ピリミジン系薬剤およびプリン代謝拮抗剤-各薬剤に特異的な体制機構とその克服-"宇宙堂八木書店. 10 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Mizunuma N.,et al.: "In vitro selection of a high-affinity RNA sequence that serves as a Thymidylate synthase-rasponse enhancer element"J.Nucreic Acids. (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Chu E.,Mizunuma N.et al.: "Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex"Molecular and Cellular Biology. 19・2. 1582-1594 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mizumuna N.,Aiba K.et al.: "Intermittent exposure of 5-fluorouracil, on and off schedule, shows high cytotoxicity in a colon cancer cell line"Proc.Am.Ass.Cancer Res.. 40. 399 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Aiba K.et al.: "An in vitro intermittent exposure to 5-fluorouracil, on and off schedule, shows high cytotoxicity in human colon cell lines"Proc.Am.Ass.Cancer Res.. 39. (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 相羽惠介 他: "5-fluorouracilとLow Dose Cisplatinとの併用療法および新規経口抗癌剤S-1の理論"癌と化学療法. 26・4. 456-466 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 相羽惠介: "代謝拮抗物質"カレントテラピー. 17・11. 36-46 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Aiba K,: "Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR." Anticancer Res. 18. 1457-1464 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Aiba K.: "Effects of Systemic and Regional Chemotheraphy After Hepatic Resection for Colorectal" Annals of Surgical Oncology. 5(8). 706-712 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 相羽恵介: "S-1, Tomudex, Capecitabine" 癌の臨床. 43(8). 826-835 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Aiba K.: "Recent advance in chemotherapy for colorectal cancer." Jpn J Cancer Chemother. 23. 535-548 (1996)

    • Related Report
      1998 Annual Research Report
  • [Publications] Aiba,K.: "Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in in vitro and in vivo." Jpn J Cancer Chemother. 23. 721-731 (1996)

    • Related Report
      1998 Annual Research Report
  • [Publications] Aiba K: "Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil." Biochem Pharm. 49. 1419-1426 (1995)

    • Related Report
      1998 Annual Research Report
  • [Publications] 相羽恵介: "代謝拮抗物質、Yellow Book3抗癌剤." 高橋隆一総監修、小川一誠監修. 東京ミクス, 57 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 相羽恵介: "Biochemical modulation、メディカル用語ライブラリー." 垣添忠生・関谷剛男編. 羊土社, 3 (1996)

    • Related Report
      1998 Annual Research Report
  • [Publications] Aiba,Keisuke: "The analysis of the innate pathways of 5-flvorouracil phosphorylation in human gastro intestinal cancer cell lines" Oncology Reports. 4. 1188-1194 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Mizunuma Nobuyuki: "An in vitro intermittent eyposure to 5-flvorouracil slows high toxiuity in colon cancer cell lines" PROC.AACR. 38. 4137 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] Aiba,Keisuke: "Thymidylato synthase gene amplitication in human colon cancer lines resistant to 5-flvorouracil" Bio chemical Pharmacology. 49. 1419-1426 (1995)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi